Medical Device News Magazine

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

“The Decipher Prostate test’s ability to help guide treatment for [...]

By |2024-09-15T13:38:47+00:00September 15, 2024|3rd Party Medical Device Industry News|Comments Off on New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
Go to Top